0 Evaluaciones
ID

31183

Descripción

Study ID: 104505 Clinical Study ID: BEX104505 Study Title: Phase II Study of Iodine 131 Anti B1 Antibody for 1st or 2nd Relapsed Indolent B-Cell Lymphomas or B-Cell Lymphomas That Have Transformed to a More Aggressive Histology Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00950755 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: tositumomab Trade Name: Bexxar Study Indication: Lymphoma, Non-Hodgkin Please record all concomitant medications and transfusions from the time of study entry through the Week 13 visit. Include study-required medications (i.e. Lugol's solution or potassium iodide, paracetamol, and diphenhydramine).

Palabras clave

Versiones (1)
  1. 25/7/18 25/7/18 -
Titular de derechos de autor

see clinicaltrials.gov

Subido en

25 de julio de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

  • El más nuevo
  • Más antiguo
  • Popular
  • El más nuevo
    • El más nuevo
    • Más antiguo
    • Popular

    Sin comentarios

    Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

    Iodine 131 B1 Antibody for B-Cell Lymphomas NCT00950755

    Inglés

    Concomitant Medications & Transfusions

    1 formularios  
    Administrative Data
    Descripción

    Administrative Data

    Alias
    UMLS CUI-1
    C1320722
    Site Number
    Descripción

    Site number

    Tipo de datos

    text

    Alias
    UMLS CUI [1,1]
    C0018704
    UMLS CUI [1,2]
    C0600091
    Patient Number
    Descripción

    Patient Number

    Tipo de datos

    text

    Alias
    UMLS CUI [1]
    C1830427
    Patient Initials
    Descripción

    Patient Initials

    Tipo de datos

    text

    Alias
    UMLS CUI [1]
    C2986440
    Concomitant Medications; Concomitant Transfusions
    Descripción

    Concomitant Medications; Concomitant Transfusions

    Alias
    UMLS CUI-1
    C2347852
    Drug Name or Blood Product
    Descripción

    Concomitant Agent; Drug Name or Blood Product

    Tipo de datos

    text

    Alias
    UMLS CUI [1,1]
    C2347852
    UMLS CUI [1,2]
    C2360065
    UMLS CUI [1,3]
    C0456388
    Dose
    Descripción

    Concomitant Agent; Dose

    Tipo de datos

    text

    Alias
    UMLS CUI [1,1]
    C2347852
    UMLS CUI [1,2]
    C3174092
    Unit
    Descripción

    Concomitant Agent; Unit

    Tipo de datos

    text

    Alias
    UMLS CUI [1,1]
    C2347852
    UMLS CUI [1,2]
    C1519795
    Route
    Descripción

    Concomitant Agent; Route

    Tipo de datos

    text

    Alias
    UMLS CUI [1,1]
    C2347852
    UMLS CUI [1,2]
    C0013153
    Frequency
    Descripción

    Concomitant Agent; Frequency

    Tipo de datos

    text

    Alias
    UMLS CUI [1,1]
    C2347852
    UMLS CUI [1,2]
    C3476109
    Start Date
    Descripción

    Concomitant Agent; Start Date

    Tipo de datos

    date

    Alias
    UMLS CUI [1]
    C2826734
    End Date
    Descripción

    Concomitant Agent; End Date

    Tipo de datos

    date

    Alias
    UMLS CUI [1]
    C2826744
    Volver a la parte superior de la página

    Similar models

    Concomitant Medications & Transfusions

    1 formularios
    Name
    Tipo
    Description | Question | Decode (Coded Value)
    Tipo de datos
    Alias
    Item Group
    Administrative Data
    C1320722 (UMLS CUI-1)
    Site number
    Item
    Site Number
    text
    C0018704 (UMLS CUI [1,1])
    C0600091 (UMLS CUI [1,2])
    Patient Number
    Item
    Patient Number
    text
    C1830427 (UMLS CUI [1])
    Patient Initials
    Item
    Patient Initials
    text
    C2986440 (UMLS CUI [1])
    Item Group
    Concomitant Medications; Concomitant Transfusions
    C2347852 (UMLS CUI-1)
    Concomitant Agent; Drug Name or Blood Product
    Item
    Drug Name or Blood Product
    text
    C2347852 (UMLS CUI [1,1])
    C2360065 (UMLS CUI [1,2])
    C0456388 (UMLS CUI [1,3])
    Concomitant Agent; Dose
    Item
    Dose
    text
    C2347852 (UMLS CUI [1,1])
    C3174092 (UMLS CUI [1,2])
    Concomitant Agent; Unit
    Item
    Unit
    text
    C2347852 (UMLS CUI [1,1])
    C1519795 (UMLS CUI [1,2])
    Concomitant Agent; Route
    Item
    Route
    text
    C2347852 (UMLS CUI [1,1])
    C0013153 (UMLS CUI [1,2])
    Concomitant Agent; Frequency
    Item
    Frequency
    text
    C2347852 (UMLS CUI [1,1])
    C3476109 (UMLS CUI [1,2])
    Concomitant Agent; Start Date
    Item
    Start Date
    date
    C2826734 (UMLS CUI [1])
    Concomitant Agent; End Date
    Item
    End Date
    date
    C2826744 (UMLS CUI [1])
    Volver a la parte superior de la página 

    Ayuda

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial